13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol,
13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol,
alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17,
Cerazette,
Desogestrel,
Marvelon,
Org 2969,
Org-2969,
Org2969,
DESOGESTREL,
54024-22-5,
Cerazette,
Desogestrelum,
desogen,
Org-2969,
Desogestrelum [INN-Latin],
ORG 2969,
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol,
UNII-81K9V7M3A3,
HSDB 3593,
EINECS 258-929-4,
CHEBI:4453,
C22H30O,
81K9V7M3A3,
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol,
NCGC00167449-01,
18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-,
13-ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17alpha-ol,
Desogestrel [USAN:BAN:INN],
SR-01000883959,
Desogestrel (USAN/INN),
Desogestrel [USAN:INN:BAN],
MFCD00869346,
13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol,
DSSTox_CID_2898,
CHEMBL1533,
DSSTox_RID_76779,
DSSTox_GSID_22898,
SCHEMBL41341,
AC1L24T4,
AC1Q282A,
GTPL7065,
DTXSID6022898,
CTK8F9084,
RPLCPCMSCLEKRS-BPIQYHPVSA-N,
17alpha-ethynyl-11-methylidene-18a-homo-estr-4-en-17beta-ol,
BCP18794,
ZINC4097416,
Tox21_112453,
AC-308,
BDBM50423510,
LMST02030104,
s4638,
(17alpha)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol,
AKOS015963198,
ACN-037024,
CS-3686,
DB00304,
VA10694,
AN-15971,
AS-13022,
BC216009,
CC-26355,
HY-12516,
LS-62079,
SC-16229,
CAS-54024-22-5,
B4976,
D4163,
FT-0640213,
C07629,
D02367,
Desogestrel, VETRANAL(TM), analytical standard,
024D225,
C-19240,
J-520217,
SR-01000883959-1,
SR-01000883959-2,
17alpha-ethynyl-13beta-ethyl-11-methylene-4-gonen-17-ol,
Desogestrel, British Pharmacopoeia (BP) Reference Standard,
Desogestrel, European Pharmacopoeia (EP) Reference Standard,
Desogestrel, United States Pharmacopeia (USP) Reference Standard,
Desogestrel, Pharmaceutical Secondary Standard; Certified Reference Material,
18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17-alpha)-,
Desogestrel for system suitability, European Pharmacopoeia (EP) Reference Standard,
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol,
Cyclessa,
Marvelon,
Mircette,
Kariva,
Cyclosa,
ortho-Cept,
Mixture Name,
D06CGB,
Org2969,
Organon Brand of Desogestrel,
CID40973,
C22-H30-O,
CS-O-01372,
DESOGESTREL AND ETHINYL ESTRADIOL,
H044,
D017135,
17-Ethynyl-18-methyl-11-methyleneestr-4-en-17beta-ol,
13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol,
alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17,
(+)-13beta-Ethyl-17alpha-ethynyl-11-methylenegon-4-en-17beta-ol,
17-alpha-ethynyl-18-methyl-11-methylene-delta-4-estren-17-beta-ol,
(+)-13.beta.-etil-etinil-17.alfa.-11-metilenegon-4-en-ol-17.beta.,
13-Ethyl-11-methylene-18 19-dinor-17alpha-4-pregnen-20-yn-17-ol,
18,19-Dinorpregn-4-en-20-in-17-ol, 13-etil-11-metileno-, (17alfa)-,
18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17.alpha.)-,
Desogestrel, 99%, a third-generation 19-nortestosterone derivative progestogen - 100mg 100mg,
SDS
COA
